Suhas D Shelukar

Title: The Innovative Contributions of Suhas D Shelukar

Introduction

Suhas D Shelukar is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compositions aimed at treating various disorders. His work is characterized by a focus on innovative solutions that address critical health issues.

Latest Patents

Suhas D Shelukar holds 1 patent for a pharmaceutical composition of a tachykinin receptor antagonist. This invention is directed towards a compound known as 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine. The pharmaceutical compositions developed through this invention are useful in the treatment or prevention of disorders such as psychiatric conditions, including depression and anxiety, as well as inflammatory diseases and emesis.

Career Highlights

Suhas D Shelukar is currently associated with Merck Sharp & Dohme Corp., a leading global healthcare company. His role at Merck has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His innovative approach has positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Suhas has collaborated with esteemed colleagues, including H William Bosch and Elaine Liversidge. These collaborations have fostered an environment of innovation and have led to advancements in pharmaceutical research.

Conclusion

Suhas D Shelukar's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in addressing complex health challenges. His work continues to influence the development of effective treatments for various disorders.